It has been found that the aberrant glycosylation of IgA mainly appears in the serum of patients with colorectal and breast cancers, which provides an important theoretical basis for the early diagnosis of such diseases (Lomax-Browne et al., 2019; Zhang et al., 2019). The gene discussed is CD79A; the disease is breast cancer.